This article was revised on July 29, 2020, to update the effective timeline.
AmeriHealth is committed to ensuring that our members have access to the care they need during the COVID-19 pandemic. We encourage all AmeriHealth members and providers to visit our dedicated
AmeriHealth New Jersey and
AmeriHealth Pennsylvania COVID-19 webpages regularly for the latest news and updates. We will continue to evaluate member needs as the situation changes.
Home visit for specimen collection for COVID-19 testing
From March 6, 2020, through September 4, 2020, AmeriHealth is waiving the requirement that a member must be homebound to receive COVID-19 specimen collection at home. This coverage decision is subject to re-evaluation for the duration of the public health emergency.
Members are no longer required to be homebound (as defined in the medical policy) to receive a nurse visit from a home health agency or trained laboratory technician for the purpose of laboratory specimen collection for COVID-19 testing in their home, when the visit for specimen collection:
- is medically necessary/appropriate for the individual’s condition; and,
- has been ordered by a licensed or otherwise qualified health care professional provider.
The specimen must be delivered to an authorized laboratory to perform the test and the results sent to the prescribing/ordering professional provider.
Note: AmeriHealth participating providers, in accordance with their provider agreement, are required to refer specimens to participating laboratories.
Please note that precertification for home care services is required.
Home care agencies should use Revenue Code 0551 Skilled Nursing – Visit Charge and specimen collection by trained laboratory technicians should be reported with HCPCS code G2023 or G2024 when submitting the claim.
You can view the complete announcement,
Home Specimen Collection for COVID-19 Testing (Updated April 14, 2020), on our
Medical Policy Portal in the News & Announcements section.
For more information about the AmeriHealth position on COVID-19, please review the following resources: